Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses
出版年份 2018 全文链接
标题
Effective Combination Adjuvants Engage Both TLR and Inflammasome Pathways To Promote Potent Adaptive Immune Responses
作者
关键词
-
出版物
JOURNAL OF IMMUNOLOGY
Volume 201, Issue 1, Pages 98-112
出版商
The American Association of Immunologists
发表日期
2018-05-16
DOI
10.4049/jimmunol.1701604
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Extracellular ATP signaling and clinical relevance
- (2018) Lei Dou et al. CLINICAL IMMUNOLOGY
- Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
- (2017) Wivine Burny et al. Frontiers in Immunology
- A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
- (2017) Neal Van Hoeven et al. Scientific Reports
- Adjuvant system AS01: helping to overcome the challenges of modern vaccines
- (2016) Arnaud M. Didierlaurent et al. Expert Review of Vaccines
- Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach
- (2016) Christopher B. Fox et al. JOURNAL OF CONTROLLED RELEASE
- Contamination of DNase Preparations Confounds Analysis of the Role of DNA in Alum-Adjuvanted Vaccines
- (2016) Laura E. Noges et al. JOURNAL OF IMMUNOLOGY
- IL-18 and Subcapsular Lymph Node Macrophages are Essential for Enhanced B Cell Responses with TLR4 Agonist Adjuvants
- (2016) Anthony L. Desbien et al. JOURNAL OF IMMUNOLOGY
- A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant
- (2016) Judith Falloon et al. VACCINE
- Schistosomiasis vaccine candidate Sm14/GLA-SE: Phase 1 safety and immunogenicity clinical trial in healthy, male adults
- (2016) Marilia Santini-Oliveira et al. VACCINE
- From discovery to licensure, the Adjuvant System story
- (2016) Nathalie Garçon et al. Human Vaccines & Immunotherapeutics
- A Novel Synthetic TLR-4 Agonist Adjuvant Increases the Protective Response to a Clinical-Stage West Nile Virus Vaccine Antigen in Multiple Formulations
- (2016) Neal Van Hoeven et al. PLoS One
- The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction
- (2016) Natasha Dubois Cauwelaert et al. PLoS One
- Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01
- (2016) Sophie Detienne et al. Scientific Reports
- Comparative Systems Analyses Reveal Molecular Signatures of Clinically tested Vaccine Adjuvants
- (2016) Thorunn A. Olafsdottir et al. Scientific Reports
- Design and preclinical characterization of a novel vaccine adjuvant formulation consisting of a synthetic TLR4 agonist in a thermoreversible squalene emulsion
- (2015) Jean Haensler et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Identification of QS-21 as an Inflammasome-activating Molecular Component of Saponin Adjuvants
- (2015) Robyn Marty-Roix et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Squalene emulsion potentiates the adjuvant activity of the TLR4 agonist, GLA, via inflammatory caspases, IL-18, and IFN-γ
- (2014) Anthony L. Desbien et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Cutting Edge: Alum Adjuvant Stimulates Inflammatory Dendritic Cells through Activation of the NALP3 Inflammasome
- (2014) M. Kool et al. JOURNAL OF IMMUNOLOGY
- Cutting Edge: Inflammasome Activation by Alum and Alum's Adjuvant Effect Are Mediated by NLRP3
- (2014) H. Li et al. JOURNAL OF IMMUNOLOGY
- Immune Subdominant Antigens as Vaccine Candidates againstMycobacterium tuberculosis
- (2014) Mark T. Orr et al. JOURNAL OF IMMUNOLOGY
- A Dual TLR Agonist Adjuvant Enhances the Immunogenicity and Protective Efficacy of the Tuberculosis Vaccine Antigen ID93
- (2014) Mark T. Orr et al. PLoS One
- MyD88 and TRIF synergistic interaction is required for TH1-cell polarization with a synthetic TLR4 agonist adjuvant
- (2013) Mark T. Orr et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis
- (2013) Mark T. Orr et al. JOURNAL OF CONTROLLED RELEASE
- IL-1 enhances expansion, effector function, tissue localization, and memory response of antigen-specific CD8 T cells
- (2013) Shlomo Z. Ben-Sasson et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Key roles of adjuvants in modern vaccines
- (2013) Steven G Reed et al. NATURE MEDICINE
- The adjuvant MF59 induces ATP release from muscle that potentiates response to vaccination
- (2013) M. Vono et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Noncanonical Inflammasome Activation by Intracellular LPS Independent of TLR4
- (2013) N. Kayagaki et al. SCIENCE
- Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5/Indonesia/05/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant
- (2013) John J. Treanor et al. VACCINE
- ATP release and purinergic signaling in NLRP3 inflammasome activation
- (2013) Aurélie Gombault et al. Frontiers in Immunology
- Immunomodulatory and Physical Effects of Phospholipid Composition in Vaccine Adjuvant Emulsions
- (2012) Christopher B. Fox et al. AAPS PHARMSCITECH
- Immunoregulation through extracellular nucleotides
- (2012) L. Vitiello et al. BLOOD
- A Comparative Study of Stress-mediated Immunological Functions with the Adjuvanticity of Alum
- (2012) Yufei Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The mechanism of action of MF59 – An innately attractive adjuvant formulation
- (2012) D.T. O’Hagan et al. VACCINE
- ATP release and purinergic signaling: a common pathway for particle-mediated inflammasome activation
- (2012) N Riteau et al. Cell Death & Disease
- MF59 oil-in-water emulsion in combination with a synthetic TLR4 agonist (E6020) is a potent adjuvant for a combination Meningococcus vaccine
- (2012) Manmohan Singh et al. Human Vaccines & Immunotherapeutics
- Follicular Helper CD4 T Cells (TFH)
- (2011) Shane Crotty Annual Review of Immunology
- Interpretation of cellular proliferation data: Avoid the panglossian
- (2011) Mario Roederer CYTOMETRY PART A
- Real-time Imaging Reveals That P2Y2and P2Y12Receptor Agonists Are Not Chemoattractants and Macrophage Chemotaxis to Complement C5a Is Phosphatidylinositol 3-Kinase (PI3K)- and p38 Mitogen-activated Protein Kinase (MAPK)-independent
- (2011) Katrin Isfort et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The inflammasome adaptor ASC regulates the function of adaptive immune cells by controlling Dock2-mediated Rac activation and actin polymerization
- (2011) Sirish K Ippagunta et al. NATURE IMMUNOLOGY
- DNA released from dying host cells mediates aluminum adjuvant activity
- (2011) Thomas Marichal et al. NATURE MEDICINE
- Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant
- (2011) Rhea N. Coler et al. PLoS One
- Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88
- (2011) A. Seubert et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammasome-independent role of the apoptosis-associated speck-like protein containing CARD (ASC) in the adjuvant effect of MF59
- (2011) A. H. Ellebedy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Inflammasome activation and IL-1 target IL-1 for secretion as opposed to surface expression
- (2011) A. Fettelschoss et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Immunomodulatory and physical effects of oil composition in vaccine adjuvant emulsions
- (2011) Christopher B. Fox et al. VACCINE
- The Inflammasomes
- (2010) Kate Schroder et al. CELL
- Effects of emulsifier concentration, composition, and order of addition in squalene-phosphatidylcholine oil-in-water emulsions
- (2010) Christopher B. Fox et al. PHARMACEUTICAL DEVELOPMENT AND TECHNOLOGY
- Bothrops snake myotoxins induce a large efflux of ATP and potassium with spreading of cell damage and pain
- (2010) M. Cintra-Francischinelli et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Interleukin-1 (IL-1 ) Processing Pathway
- (2010) A. Weber et al. Science Signaling
- Interleukin-1 (IL-1) Pathway
- (2010) A. Weber et al. Science Signaling
- Autocrine Purinergic Receptor Signaling Is Essential for Macrophage Chemotaxis
- (2010) M. Kronlage et al. Science Signaling
- Alum Induces Innate Immune Responses through Macrophage and Mast Cell Sensors, But These Sensors Are Not Required for Alum to Act As an Adjuvant for Specific Immunity
- (2009) A. S. McKee et al. JOURNAL OF IMMUNOLOGY
- AS04, an Aluminum Salt- and TLR4 Agonist-Based Adjuvant System, Induces a Transient Localized Innate Immune Response Leading to Enhanced Adaptive Immunity
- (2009) A. M. Didierlaurent et al. JOURNAL OF IMMUNOLOGY
- MF59 Emulsion Is an Effective Delivery System for a Synthetic TLR4 Agonist (E6020)
- (2009) Barbara C. Baudner et al. PHARMACEUTICAL RESEARCH
- IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation
- (2009) S. Z. Ben-Sasson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Extracellular ATP in the Immune System: More Than Just a "Danger Signal"
- (2009) A. Trautmann Science Signaling
- The Nlrp3 inflammasome is critical for aluminium hydroxide-mediated IL-1β secretion but dispensable for adjuvant activity
- (2008) Luigi Franchi et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Alum adjuvant boosts adaptive immunity by inducing uric acid and activating inflammatory dendritic cells
- (2008) Mirjam Kool et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Innate Immune Activation Through Nalp3 Inflammasome Sensing of Asbestos and Silica
- (2008) C. Dostert et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More